Literature DB >> 22882350

Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.

Alison J Birtle1, Rebecca Lewis, Mark Johnson, Emma Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22882350     DOI： 10.1111/j.1464-410X.2012.11413.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy.

Authors:  Pierre Colin; Tarek P Ghoneim; Laurent Nison; Thomas Seisen; Eric Lechevallier; Xavier Cathelineau; Adil Ouzzane; Marc Zerbib; Jean-Alexandre Long; Alain Ruffion; Sébastien Crouzet; Olivier Cussenot; Marie Audouin; Jacques Irani; Solène Gardic; Pascal Gres; François Audenet; Mathieu Roumiguié; Antoine Valeri; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-06-29       Impact factor: 4.226

2.  Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.

Authors:  Matthew R Danzig; Katherine Mallin; James M McKiernan; Walter M Stadler; Srikala S Sridhar; Todd M Morgan; Bernard H Bochner; Cheryl T Lee
Journal:  Cancer       Date:  2018-04-06       Impact factor: 6.860

Review 3.  Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.

Authors:  Atiqullah Aziz; Jakub Dobruch; Kees Hendricksen; Luis A Kluth; Andrea Necchi; Aidan Noon; Michael Rink; Florian Roghmann; Roland Seiler; Paolo Gontero; Wassim Kassouf; Shahrokh F Shariat; Evanguelos Xylinas
Journal:  World J Urol       Date:  2017-01-10       Impact factor: 4.226

Review 4.  Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.

Authors:  Jan Cordier; Guru Sonpavde; Christian G Stief; Derya Tilki
Journal:  World J Urol       Date:  2012-09-29       Impact factor: 4.226

5.  Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

Authors:  Nessn H Azawi; Kasper Drimer Berg; Andreas Key Milan Thamsborg; Claus Dahl; Jan Viberg Jepsen; Bjarne Kroman-Andersen; Johan Poulsen; Helle Handler Petersen; L Henning Olsen; Jørgen Bjerggaard Jensen
Journal:  Int Urol Nephrol       Date:  2017-07-31       Impact factor: 2.370

Review 6.  Current role of lymphadenectomy in the upper tract urothelial carcinoma.

Authors:  Mario Alvarez-Maestro; Juan Gómez Rivas; Sergio Alonso Y Gregorio; Cristina de Castro Guerin; Ángel Tabernero Gómez; Jesús Cisneros Ledo
Journal:  Cent European J Urol       Date:  2016-11-30

7.  The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma.

Authors:  Taek Sang Kim; Jeong Hyun Oh; Hyun Yul Rhew
Journal:  J Cancer       Date:  2013-10-05       Impact factor: 4.207

8.  Conditional Survival and Associated Prognostic Factors in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Retrospective Study at a Single Institution.

Authors:  Minyong Kang; Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Cancer Res Treat       Date:  2015-09-09       Impact factor: 4.679

Review 9.  Upper urinary tract disease: what we know today and unmet needs.

Authors:  Romain Mathieu; Karim Bensalah; Ilaria Lucca; Aurélie Mbeutcha; Morgan Rouprêt; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2015-06

10.  Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.

Authors:  Leila Rooshenas; Daisy Elliott; Julia Wade; Marcus Jepson; Sangeetha Paramasivan; Sean Strong; Caroline Wilson; David Beard; Jane M Blazeby; Alison Birtle; Alison Halliday; Chris A Rogers; Rob Stein; Jenny L Donovan
Journal:  PLoS Med       Date:  2016-10-18       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.